Name | Tofacitinib (CP-690550) Citrate | CAS# | 540737-29-9 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3. |
Get all suppliers by the below link:
Tofacitinib (CP-690550) Citrate suppliers
2024-07-15 |
Tofacitinib (CP-690550) Citrate
Price: Inquiry |
2020-01-06 |
Tofacitinib (CP-690550) Citrate
Price: $150.0 |
2021-07-26 |
Tofacitinib citrate
Price: $Inquiry |
2025-09-17 |
Tofacitinib (CP-690550) Citrate
Price: ¥Inquiry |
2024-01-09 |
tofacitinib citrate
Price: $Inquiry |
2017-10-20 |
Tofacitinib (CP-690550) Citrate
Price: ¥Inquiry |
2018-02-16 |
Tofacitinib (CP-690550) Citrate
Price: ¥Inquiry |
2017-07-01 |
Tofacitinib citrate
Price: ¥Inquiry |
2017-10-10 |
Tofacitinib (CP-690550) Citrate
Price: ¥500.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved